After the report in the "Wall Street Journal" that Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is negotiating with Allergan to buy that latter's generic drugs division for $40-45 million, trading in Teva shares has been suspended on the Tel Aviv Stock Exchange this morning, pending an announcement. Published by Globes [online], Israel business news - www.globes-online.com - on July 27, 2015 © Copyright of Globes Publisher Itonut (1983) Ltd. 2015
